Microcap Fraud Task Force News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Microcap fraud task force. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Microcap Fraud Task Force Today - Breaking & Trending Today

SEC Announces Enforcement Task Force Focused on Climate and ESG Issues | Ballard Spahr LLP

To embed, copy and paste the code into your website or blog:
Today, the SEC sent a very clear signal about one of its chief enforcement priorities by
announcing the creation of a Climate and ESG Task Force within the Division of Enforcement. ESG stands for Environmental, Social, and Governance.
Since Allison Herren Lee was named the Acting Chair of the SEC on January 21, 2021, the SEC has repeatedly signaled that Climate and ESG issues and disclosures will be an SEC priority. For instance, on February 1, 2021, the SEC
announced that Acting Chair Lee would have, for the first time, a senior policy advisor solely dedicated to these issues. On February 24, 2021, Acting Chair Lee ....

United States , Ballard Spahr , Kelly Gibson , Allison Herren Lee , Division Of Corporation , Tour Working Group , Division Of Examinations , Division Of Enforcement , Microcap Fraud Task , Audit Task , Retail Strategy Task , Securities Exchange , Philadelphia Regional Office , Acting Chair , Acting Chair Lee , Corporation Finance , Retail Strategy Task Force , Financial Reporting , Audit Task Force , Microcap Fraud Task Force , Acting Deputy Director , Enforcement Kelly Gibson , Regional Director , Securities Exchange Act , Exchange Act , Securities Act ,

SEC Charges Biotech Company and CEO with Fraud Concerning COVID-19 Blood Testing Device

SEC Charges Biotech Company and CEO with Fraud Concerning COVID-19 Blood Testing Device
Washington, D.C. (Newsfile Corp. - December 18, 2020) - The Securities and Exchange Commission today announced charges against California-based biotechnology company Decision Diagnostics Corp. and its CEO, Keith Berman, with making false and misleading claims in numerous press releases that the company had developed a working, break-through technology that could accurately detect Covid-19 through a quick blood test. The SEC temporarily suspended trading in Decision Diagnostics securities on April 23, 2020.
The SEC s complaint alleges that Decision Diagnostics and Berman seized upon the global pandemic through a series of press releases that falsely claimed Decision Diagnostics had developed a finger prick blood test that could detect Covid-19 in less than a minute. According to the complaint, from March 2020 to at least June 2020, Decision Diagnostics and Berman made false and mislea ....

New York , United States , District Of Columbia , Stephanie Avakian , Hanel Kim , James Carlson , Keith Berman , Tom Bednar , Jeff Leasure , Carlisle Perkins , Margareta Cain , Kostenloser Wertpapierhandel , David Misler , Lesley Atkins , Coronavirus Steering Committee , Decision Diagnostics Corp , Dc Newsfile Corp , Financial Industry Regulatory Authority , Division Of Enforcement , Us District Court , Microcap Fraud Task , Office Of Market Intelligence , Exchange Commission , Department Of Justice Market Integrity , Decision Diagnostics , Decision Diagnostic ,

SEC.gov | SEC Charges Biotech Company and CEO With Fraud Concerning COVID-19 Blood Testing Device

FOR IMMEDIATE RELEASE
Washington D.C., Dec. 18, 2020
The Securities and Exchange Commission today announced charges against California-based biotechnology company Decision Diagnostics Corp. and its CEO, Keith Berman, with making false and misleading claims in numerous press releases that the company had developed a working, break-through technology that could accurately detect Covid-19 through a quick blood test. The SEC temporarily suspended trading in Decision Diagnostics securities on April 23, 2020.
The SEC s complaint alleges that Decision Diagnostics and Berman seized upon the global pandemic through a series of press releases that falsely claimed Decision Diagnostics had developed a finger prick blood test that could detect Covid-19 in less than a minute. According to the complaint, from March 2020 to at least June 2020, Decision Diagnostics and Berman made false and misleading statements about the existence of Decision Diagnostics Covid- ....

New York , United States , District Of Columbia , Stephanie Avakian , Hanel Kim , James Carlson , Keith Berman , Tom Bednar , Jeff Leasure , Carlisle Perkins , Margareta Cain , David Misler , Lesley Atkins , Coronavirus Steering Committee , Decision Diagnostics Corp , Financial Industry Regulatory Authority , Division Of Enforcement , Us District Court , Microcap Fraud Task , Office Of Market Intelligence , Exchange Commission , Department Of Justice Market Integrity , Decision Diagnostics , Decision Diagnostic , Associate Director , Southern District ,